Australian biopharma company EnGeneIC is developing the world’s first COVID-19 vaccine which can offer immunity ag...
Asia Pacific is home to more than half of the world’s population and bears a significant burden of infectious dise...
Australia's University of Queensland (UQ) researchers are calling for an urgent review of low influenza vaccination rate...
Japanese pharmaceutical firm Takeda has announced that its dengue vaccine candidate, TAK-003, prevented 8...
A new study jointly conducted by South Korea-based International Vaccine Institute (IVI) and collaborators shows multido...
SINOVAC Biotech, a leading provider of biopharmaceutical products in China, has received the World Health Organization (...
Daiichi Sankyo has announced the current progress of development of DS-5670, an mRNA vaccine, being evaluated in Japan a...
Moderna and Takeda have announced to transfer the marketing authorization in Japan for Moderna’s COVID-1...
South Korea-based International Vaccine Institute (IVI) and Armauer Hansen Research Institute (AHRI), established by the...
The University of Auckland in New Zealand has received budget funding of $40.7 million for development of novel mRNA vac...
The World Health Organization (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by ...
The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea (ROK),...
South Korea-based SK Bioscience has secured another approval for in-house vaccine. SK Bioscience obtained an export lic...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is providing funding of up to $19.3 million to suppo...
Jiangsu Recbio Technology Co., Ltd. has recently received the clinical trial approval for its recombinant protein COVID-...
Intravacc B.V., located at Utrecht Science Park Bilthoven in the Netherlands, has announced the signing o...
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...
